Chronic Migraine Hormonal Changes: BOTOX & Treatment

Chronic Migraine, Hormonal Changes, and BOTOX: When Broader Medical Evaluation Matters

Abstract

Chronic migraine is more than a recurring headache. For many women, migraine frequency and severity can change with menstruation, perimenopause, sleep disruption, medication use, stress, and other medical conditions. BOTOX® (onabotulinumtoxinA) is an FDA-approved preventive treatment for appropriately selected adults with chronic migraine, but injections are only one part of a thoughtful treatment plan. A broader medical evaluation can help determine whether medication-overuse patterns, changing menstrual cycles, sleep problems, cardiovascular risk factors, or other health issues are adding to a patient’s migraine burden. Importantly, this does not mean every patient needs extensive hormone testing. The goal is targeted evaluation, accurate diagnosis, and individualized prevention.

When the Migraine Calendar Suddenly Changes

Marisol had lived with migraine for years, but something had changed.

At first, she blamed her increasingly unpredictable headaches on work. She was sleeping poorly, her menstrual cycles were becoming irregular, and some months she experienced headaches several times a week. She kept sumatriptan in her purse, ibuprofen in her desk, and another bottle of pain reliever at home.

Eventually, Marisol realized that she was planning her life around medication.

She was not simply asking, “What can stop today’s migraine?”

She needed another question answered:

Why are my migraine days becoming so frequent, and what can we do to prevent them?

That distinction matters because chronic migraine usually requires a different strategy from occasional migraine attacks. The medical evaluation should consider the entire pattern—not just the pain on the day of the appointment.

For some patients, hormonal fluctuations are part of that pattern. For others, poor sleep, medication overuse, hypertension, mood symptoms, neck pain, menopause symptoms, or another health condition may be contributing. Often, several factors overlap.

That is where a broader internal medicine evaluation becomes valuable.

Hormones Can Influence Migraine Without Being the Whole Explanation

Migraine disproportionately affects women, and changing estrogen levels appear to influence migraine susceptibility throughout the reproductive lifespan. Menstruation, pregnancy, perimenopause, menopause, contraception, and menopausal hormone therapy can therefore coincide with changes in headache patterns.

Current reviews indicate that the hormonal instability occurring during perimenopause can make migraine attacks more frequent or less predictable in some patients. Menstrually related migraines may become especially noticeable during this transition. After natural menopause, migraine without aura often improves as hormone levels stabilize, although that improvement is not universal (Friedman Korn & Bernstein, 2026; Kamourieh & MacGregor, 2026).

The relationship is more complicated than simply saying “low estrogen causes migraine.”

Migraine biology includes trigeminal nerve signaling, calcitonin gene-related peptide activity, sensory processing, genetics, sleep, pain sensitization, environmental triggers, stress responses, medications, and other biological systems. Hormonal fluctuations may influence this network rather than functioning as a single on-or-off cause (Waliszewska-Prosół et al., 2025).

That is why medical evaluation should begin with the patient’s history rather than automatically ordering a large hormone panel.

Menstrual Migraine: Timing Can Tell Us a Lot

A headache diary can sometimes reveal more than a single laboratory value.

A patient may notice that migraine attacks repeatedly cluster immediately before menstruation or during the first several days of bleeding. Another patient may experience no meaningful relationship between migraine and the menstrual cycle.

Tracking these patterns can help the clinician determine whether menstruation appears to be a reliable trigger.

Useful information to record includes:

• headache days and migraine days each month;
• menstrual cycle dates and changes in cycle regularity;
• medications taken for each attack;
• sleep duration and major sleep disruptions;
• migraine features such as nausea, light sensitivity, sound sensitivity, or aura;
• missed work, exercise, family activities, and other measures of disability;
• new medications, contraceptives, or hormone therapy; and
• major changes in stress, nutrition, caffeine use, hydration, or other health symptoms.

This record can also help determine whether the patient is transitioning from episodic migraine toward chronic migraine.

The clinic’s patient education on migraine patterns, lifestyle factors, and headache diaries provides additional background through its Migraine Treatment resource. Migraine Treatment at DrAlexJimenez.com

Perimenopause Does Not Automatically Mean You Need Hormone Testing

One of the most important points for patients is that perimenopause is usually a clinical diagnosis.

The American College of Obstetricians and Gynecologists explains that most patients do not routinely need hormone testing simply to determine whether they are entering perimenopause. Age, symptoms, menstrual changes, and medical history often provide the necessary information. Hormone testing may become more relevant when symptoms occur at an unusually young age or when another condition must be investigated (American College of Obstetricians and Gynecologists, 2025).

This matters because estrogen and other reproductive hormones can fluctuate considerably during the menopause transition. A single blood draw may capture only one moment in a constantly changing hormonal environment.

For the migraine patient, the better question is not:

“What hormone panel does every patient need?”

It is:

“What information would actually change this patient’s diagnosis or treatment?”

Depending on the history, a clinician may instead need to consider thyroid disease, anemia, cardiovascular risk, pregnancy, medication effects, sleep disorders, metabolic conditions, abnormal bleeding, or another diagnosis. Laboratory testing should answer a defined clinical question rather than become a routine requirement simply because migraine and perimenopause occur together.

The clinic discusses this individualized approach to hormonal health in its educational material on Patient Wellness and Health With Bioidentical Hormones. Patient Wellness and Health With Bioidentical Hormones

What BOTOX Does—and What It Does Not Do

BOTOX occupies a very specific place in migraine care.

According to current prescribing information, BOTOX is FDA-approved for the prevention of headaches in adults with chronic migraine, defined in the indication as at least 15 headache days per month with headaches lasting four hours per day or longer. Its safety and effectiveness have not been established for preventing episodic migraine involving 14 or fewer headache days per month (AbbVie Inc., 2026).

Clinical headache classifications add another important detail: chronic migraine generally involves at least 15 headache days per month for more than three months, with migraine features present on at least eight days.

BOTOX therefore is not simply an injection offered whenever someone reports frequent headaches.

The diagnosis comes first.

When BOTOX is appropriate, the FDA-recommended chronic-migraine protocol uses 155 units distributed among 31 injection sites involving specific muscles of the forehead, temples, back of the head, neck, and shoulders, with retreatment generally performed every 12 weeks (AbbVie Inc., 2026).

Most importantly, BOTOX is a preventive treatment.

It is not intended to immediately stop an active migraine attack in the way an acute medication may be used. The goal is to reduce the future burden of chronic migraine over time.

Patients can explore the clinic’s broader discussion of migraine prevention and integrated management in Integrative Treatment Explained with Chiropractic Care for Migraines. Integrative Treatment Explained With Chiropractic Care for Migraines

Frequent Acute Medication Use Deserves Attention

Back to Marisol.

When her clinician reviewed her headache diary, another pattern became obvious. She was using acute headache medication on many days each month.

That information mattered just as much as her irregular menstrual cycles.

People with frequent migraines can enter a difficult cycle: more headaches lead to more medication use, while excessive use of certain acute medications can contribute to medication-overuse headaches.

The International Classification of Headache Disorders describes medication-overuse headache as a headache occurring on at least 15 days per month in a person with a pre-existing headache disorder who has regularly overused acute or symptomatic medication for more than three months. The threshold depends on the medication involved. For example, triptans, opioids, and many combination analgesics can meet overuse criteria when used on 10 or more days per month, while simple analgesics such as acetaminophen or NSAIDs generally have a threshold of 15 or more days per month (International Headache Society, 2018).

That does not mean patients should suddenly discontinue prescribed medications on their own.

It means the prescribing clinician should know exactly how frequently acute medications are being used.

A preventive strategy may need to address both the underlying migraine disorder and the medication-use pattern.

For Marisol, the question was no longer simply whether BOTOX might be appropriate. Her clinician also needed to understand how many headache days she experienced, how many were migraine days, which acute medications she used, how frequently she used them, and whether a preventive treatment plan could reduce her reliance on rescue medication.

Sleep Can Become Part of the Migraine Cycle

Perimenopause frequently brings another challenge: disrupted sleep.

Night sweats, insomnia, changing schedules, anxiety, pain, sleep apnea, restless sleep, or simply trying to function through repeated migraine attacks can reduce sleep quality.

Migraine and sleep disturbances appear to have a bidirectional relationship. Poor sleep can be associated with greater migraine burden, while frequent migraine can further disturb sleep. Recent research has linked unusually short or long sleep duration with greater headache frequency and migraine-related disability, although association does not prove that sleep duration alone causes migraine (Omland et al., 2025; American Headache Society, 2026).

This makes sleep history an important part of a comprehensive migraine evaluation.

Sometimes better migraine prevention improves sleep because patients experience fewer painful nights. In other cases, insomnia or another sleep disorder requires its own treatment.

Either way, don’t dismiss sleep as an unrelated lifestyle detail.

Why Internal Medicine Evaluation Matters

A chronic migraine consultation should look beyond the injection sites.

An internal medicine perspective can help identify conditions that influence treatment selection or require coordination. Blood pressure, cardiovascular risk, pregnancy potential, migraine aura, medication interactions, menopause symptoms, sleep disorders, metabolic disease, thyroid concerns, mood symptoms, and other comorbidities can all influence the overall plan.

That broader perspective becomes especially important when patients take several prescription medications or are considering contraceptive or menopausal hormone therapy.

Migraine with aura, for example, deserves careful vascular-risk assessment when estrogen-containing therapies are being considered. Treatment decisions should reflect the individual patient’s age, smoking status, blood pressure, cardiovascular history, medication profile, reproductive goals, and other risks, rather than applying a single hormone rule to every patient.

Modern migraine care increasingly emphasizes individualized preventive therapy. Updated American Headache Society and American Academy of Neurology guidance reflects the expanding evidence base for migraine-prevention medications and reinforces the importance of matching preventive therapy to the patient’s clinical situation (American Headache Society, 2026).

Functional Medicine Should Be Targeted, Not a Fishing Expedition

Functional medicine can add value when it is used to organize complex information and investigate a legitimate clinical question.

For example, nutrition quality, meal timing, hydration, gastrointestinal problems, metabolic health, medication effects, and selected nutrient concerns may deserve attention in some patients.

But responsible functional medicine does not mean assuming that every chronic migraine results from a hidden nutritional deficiency, hormonal imbalance, or abnormal laboratory marker.

Testing should be purposeful.

A patient with fatigue, heavy menstrual bleeding, and migraine may require a different evaluation from a patient with migraine, snoring, hypertension, and daytime sleepiness. Another patient with irregular cycles, hot flashes, and new sleep disruption may benefit from a focused menopause assessment.

The clinic’s Understanding Functional Medicine resource explains its broader systems-based approach while emphasizing individualized evaluation. Understanding Functional Medicine

A Multidisciplinary Migraine Model in El Paso

Dr. Jimenez’s Injury Medical Chiropractic and Functional Medicine Clinic brings several clinical perspectives into one coordinated setting.

Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine and serves as medical director and collaborative physician. Her role supports medical evaluation, risk stratification, advanced laboratory interpretation when clinically indicated, assessment of comorbid medical conditions, and coordination of internal medicine treatment.

Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, is dual-licensed as a Doctor of Chiropractic and board-certified Family Practice Nurse Practitioner. His clinical work bridges soft-tissue and musculoskeletal evaluation, medical diagnostics, functional medicine, rehabilitation, and integrative treatment. The clinic’s current website also lists migraine BOTOX among the treatments it provides.

This structure can be particularly useful when a migraine patient has several overlapping concerns—for example, chronic headaches, neck and shoulder dysfunction, sleep disturbance, medication questions, menstrual changes, metabolic conditions, or possible perimenopause.

According to the clinic’s own published materials, this combination of medical-director oversight and dual-licensed DC/APRN soft-tissue expertise represents an integrated model it describes as unique in El Paso. Because an absolute “only clinic in El Paso” statement is a market-exclusivity claim, patients should understand it as the practice’s published description of its model rather than an independently audited survey of every healthcare practice in the city.

Patients can review the team’s credentials and multidisciplinary structure on the clinic’s staff page. Meet the Injury Medical Clinic PA Team

El Paso, TX Chiropractic Migraine Treatment

The Goal Is Not to Blame Every Migraine on Hormones

For patients like Marisol, finding a connection between migraine and the menstrual cycle can be useful—but it should not end the investigation.

Her headaches may reflect several interacting factors:

Hormonal variability may lower her migraine threshold during certain weeks. Poor sleep may make the nervous system more vulnerable. Frequent acute medication use may be increasing the complexity of her headache pattern. Neck discomfort may add another source of pain. Her medical history may influence which preventive medications are appropriate.

The solution is therefore not automatically “check every hormone” or “give BOTOX.”

The better approach is to define the migraine pattern, identify modifiable contributors, screen for conditions that change medical risk, and then choose prevention based on the evidence and the patient’s preferences.

That approach also protects patient autonomy. A well-informed patient should understand why a test is being ordered, why a medication is being recommended, what alternatives exist, what risks to consider, and what realistic treatment goals look like.

When BOTOX Becomes One Piece of a Larger Prevention Plan

For an appropriately diagnosed adult with chronic migraine, BOTOX may provide an important preventive option.

But the most complete migraine plan may also require attention to medication use, sleep, menstrual patterns, menopause symptoms, nutrition, stress, physical function, cardiovascular factors, and other medical conditions.

That is the advantage of broader evaluation.

Instead of treating every headache as an isolated event, the healthcare team can ask what is changing across the entire month.

For Marisol, that shift in thinking was important. Her headache diary gave her clinicians information that no single blood test could provide. It showed when the headaches occurred, how often she relied on acute medication, how her cycle was changing, and how sleep disruption affected her ability to function.

Most importantly, it helped transform treatment from repeatedly reacting to migraine attacks into building a coordinated prevention strategy.

For patients experiencing frequent headaches, menstrual or perimenopausal changes, increasing use of acute medication, or questions about BOTOX for chronic migraine, a comprehensive evaluation can help determine what deserves treatment—and what does not need unnecessary testing.

The objective is not more treatment for its own sake.

It is the right treatment for the right patient, supported by careful diagnosis, medical oversight, patient education, and informed choice.

---

References

AbbVie Inc. (2026). BOTOX (onabotulinumtoxinA) prescribing information. BOTOX Prescribing Information

American College of Obstetricians and Gynecologists. (2025). Do I need to have testing of my hormone levels during perimenopause? ACOG Perimenopause Hormone Testing Guidance

American Headache Society. (2026). Updated guideline on migraine prevention medications for adults. American Headache Society Migraine Prevention Guideline Update

Friedman Korn, T., & Bernstein, C. (2026). Migraine across the menopausal transition and beyond: A narrative review. Headache, 66(6), 1390–1404. https://doi.org/10.1111/head.70071.

Kamourieh, S., & MacGregor, E. A. (2026). Perimenopausal migraine: A narrative review. Climacteric, 29(4), 507–515. https://doi.org/10.1080/13697137.2026.2675559.

Omland, P. M., et al. (2025). Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine. Cephalalgia, 45(3). https://doi.org/10.1177/03331024251329400.

Waliszewska-Prosół, M., Grandi, G., Ornello, R., Raffaelli, B., Straburzyński, M., Tana, C., & Martelletti, P. (2025). Menopause, perimenopause, and migraine: Understanding the intersections and implications for treatment. Pain and Therapy, 14(3), 665–680. https://doi.org/10.1007/s40120-025-00720-2.

Educational disclaimer: This article is for educational purposes and does not replace individualized diagnosis or treatment by a qualified healthcare professional. Patients should discuss migraine medications, BOTOX, hormonal therapies, medication-overuse concerns, and laboratory testing with their treating clinician.